SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection.

WAPM (World Association of Perinatal Medicine) Working Group on (2021) Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection. Ultrasound Obstet Gynecol, 57 (2). pp. 232-241. ISSN 1469-0705 https://doi.org/10.1002/uog.23107
SGUL Authors: Khalil, Asma

[img]
Preview
PDF Accepted Version
Available under License ["licenses_description_publisher" not defined].

Download (1MB) | Preview

Abstract

OBJECTIVES: To evaluate the maternal and perinatal outcomes of pregnancies affected by SARS-CoV-2 infection. METHODS: This was a multinational retrospective cohort study including women with a singleton pregnancy and laboratory-confirmed SARS-CoV-2 infection, conducted in 72 centers in 22 different countries in Europe, the USA, South America, Asia and Australia, between 1 February 2020 and 30 April 2020. Confirmed SARS-CoV-2 infection was defined as a positive result on real-time reverse-transcription polymerase chain reaction (RT-PCR) assay of nasopharyngeal swab specimens. The primary outcome was a composite measure of maternal mortality and morbidity, including admission to the intensive care unit (ICU), use of mechanical ventilation and death. RESULTS: In total, 388 women with a singleton pregnancy tested positive for SARS-CoV-2 on RT-PCR of a nasopharyngeal swab and were included in the study. Composite adverse maternal outcome was observed in 47/388 (12.1%) women; 43 (11.1%) women were admitted to the ICU, 36 (9.3%) required mechanical ventilation and three (0.8%) died. Of the 388 women included in the study, 122 (31.4%) were still pregnant at the time of data analysis. Among the other 266 women, six (19.4% of the 31 women with first-trimester infection) had miscarriage, three (1.1%) had termination of pregnancy, six (2.3%) had stillbirth and 251 (94.4%) delivered a liveborn infant. The rate of preterm birth before 37 weeks' gestation was 26.3% (70/266). Of the 251 liveborn infants, 69/251 (27.5%) were admitted to the neonatal ICU, and there were five (2.0%) neonatal deaths. The overall rate of perinatal death was 4.1% (11/266). Only one (1/251, 0.4%) infant, born to a mother who tested positive during the third trimester, was found to be positive for SARS-CoV-2 on RT-PCR. CONCLUSIONS: SARS-CoV-2 infection in pregnant women is associated with a 0.8% rate of maternal mortality, but an 11.1% rate of admission to the ICU. The risk of vertical transmission seems to be negligible. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.

Item Type: Article
Additional Information: This is the peer reviewed version of the following article: (2021), Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection. Ultrasound Obstet Gynecol, 57: 232-241, which has been published in final form at https://doi.org/10.1002/uog.23107. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. This article may not be enhanced, enriched or otherwise transformed into a derivative work, without express permission from Wiley or by statutory rights under applicable legislation. Copyright notices must not be removed, obscured or modified. The article must be linked to Wiley’s version of record on Wiley Online Library and any embedding, framing or otherwise making available the article or pages thereof by third parties from platforms, services and websites other than Wiley Online Library must be prohibited.
Keywords: COVID-19, SARS-CoV-2, coronavirus, infection, pregnancy, Adult, COVID-19, Cohort Studies, Female, Hospitalization, Humans, Infant, Infant, Newborn, Intensive Care Units, Maternal Mortality, Pandemics, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, WAPM (World Association of Perinatal Medicine) Working Group on COVID-19, Humans, Pregnancy Complications, Infectious, Pregnancy Outcome, Respiration, Artificial, Hospitalization, Maternal Mortality, Retrospective Studies, Cohort Studies, Pregnancy, Adult, Infant, Infant, Newborn, Intensive Care Units, Female, Pandemics, COVID-19, SARS-CoV-2, coronavirus, COVID-19, infection, pregnancy, SARS-CoV-2, coronavirus, COVID-19, infection, pregnancy, SARS-CoV-2, COVID-19, SARS-CoV-2, coronavirus, infection, pregnancy, Adult, COVID-19, Cohort Studies, Female, Hospitalization, Humans, Infant, Infant, Newborn, Intensive Care Units, Maternal Mortality, Pandemics, Pregnancy, Pregnancy Complications, Infectious, Pregnancy Outcome, Respiration, Artificial, Retrospective Studies, SARS-CoV-2, 1114 Paediatrics and Reproductive Medicine, Obstetrics & Reproductive Medicine
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Ultrasound Obstet Gynecol
ISSN: 1469-0705
Language: eng
Dates:
DateEvent
1 February 2021Published
21 January 2021Published Online
26 August 2020Accepted
Publisher License: Publisher's own licence
PubMed ID: 32926494
Web of Science ID: WOS:000613461600006
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113682
Publisher's version: https://doi.org/10.1002/uog.23107

Actions (login required)

Edit Item Edit Item